{"id":"W4293113495","doi":"10.14740/wjon1507","title":"Prospective Cohort Study of Palbociclib Treatment in Postmenopausal Patients With Unresectable and Metastatic Hormone Receptor-Positive Breast Cancer: Study Protocol for a CSPOR-BC Palbociclib Cohort Trial","year":2022,"lang":"en","type":"article","venue":"World Journal of Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Palbociclib; Medicine; Metastatic breast cancer; Clinical endpoint; Letrozole; Breast cancer; Oncology; Internal medicine; Fulvestrant; Cohort; Cancer; Clinical trial; Adverse effect; Prospective cohort study; Quality of life (healthcare); Estrogen receptor; Tamoxifen","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01371135,0.003711628,0.003807327,0.0007073834,0.001952107,0.00214173,0.002559284,0.002395312,0.01688348],"category_scores_gemma":[0.008249288,0.001788746,0.002931962,0.001556762,0.001324955,0.001582183,0.001548533,0.003524301,0.005370587],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002587371,"about_ca_system_score_gemma":0.01109671,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002866905,"about_ca_topic_score_gemma":0.004960313,"domain_scores_codex":[0.9949032,0.002541113,0.0004660884,0.0008856478,0.0006000783,0.000603809],"domain_scores_gemma":[0.995046,0.0004520611,0.001103429,0.001009626,0.0009290122,0.001459833],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9180235,0.01294016,0.02422398,0.003129085,0.003225778,0.0003236202,0.0002795066,0.001226339,0.003466833,0.001399639,0.01598149,0.01578],"study_design_scores_gemma":[0.8513113,0.06191636,0.04812994,0.0006570219,0.002738423,0.0002472303,0.0001746584,0.001398419,0.0009906085,0.001426817,0.03086134,0.0001478922],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"protocol","genre_gemma":"protocol","genre_scores_codex":[0.1299306,0.003010852,0.005936988,0.001329584,0.0006977754,0.8211238,0.03131961,0.0002299975,0.00642077],"genre_scores_gemma":[0.1158515,0.001317169,0.006656473,0.001356361,0.0002873787,0.8553495,0.01575732,0.00004452904,0.003379669],"genre_candidate":"protocol","genre_consensus":"protocol","teacher_disagreement_score":0.01688348,"threshold_uncertainty_score":0.0725134,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01855919615992813,"score_gpt":0.3575741634008314,"score_spread":0.3390149672409032,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}